Bill
Bill > LB195
NE LB195
Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications
summary
Introduced
01/14/2025
01/14/2025
In Committee
01/16/2025
01/16/2025
Crossed Over
02/26/2025
02/26/2025
Passed
04/03/2025
04/03/2025
Dead
Signed/Enacted/Adopted
04/08/2025
04/08/2025
Introduced Session
109th Legislature
Bill Summary
A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to amend section 28-470, Revised Statutes Cumulative Supplement, 2024; to provide for immunity for conduct relating to opioid overdose reversal medications; to provide and eliminate definitions; and to repeal the original section.
AI Summary
This bill expands legal protections for individuals and professionals who obtain and administer opioid overdose reversal medications like naloxone and nalmefene during potential overdose situations. The legislation provides immunity from criminal prosecution, administrative action, and civil liability for health professionals, family members, friends, school personnel, emergency responders, and law enforcement personnel who obtain and administer these medications in good faith. The bill broadens the definition of "opioid overdose reversal medication" to include any FDA-approved lifesaving medication for reversing opioid overdoses, whether obtained by prescription, from a health professional, or over the counter. This means that more people can legally help someone experiencing an opioid overdose without fear of legal consequences, as long as they act reasonably and in good faith. The bill aims to increase access to and use of overdose reversal medications, which can be critical in saving lives during an opioid overdose emergency, by removing potential legal barriers that might discourage people from providing immediate assistance.
Committee Categories
Justice
Sponsors (1)
Last Action
Approved by Governor on April 7, 2025 (on 04/08/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=59308 |
BillText | https://nebraskalegislature.gov/FloorDocs/109/PDF/Slip/LB195.pdf |
BillText | https://nebraskalegislature.gov/FloorDocs/109/PDF/Engrossed/LB195.pdf |
BillText | https://nebraskalegislature.gov/FloorDocs/109/PDF/Final/LB195.pdf |
Bosn AM240 | https://nebraskalegislature.gov/FloorDocs/109/PDF/AM/AM240.pdf |
Judiciary AM135 | https://nebraskalegislature.gov/FloorDocs/109/PDF/AM/AM135.pdf |
Analysis - Committee Statement | https://nebraskalegislature.gov/FloorDocs/109/PDF/CS/LB195.pdf |
Fiscal Note for LB195 | https://nebraskalegislature.gov/FloorDocs/109/PDF/FN/LB195_20250122-120835.pdf |
Analysis - Statement of Intent | https://nebraskalegislature.gov/FloorDocs/109/PDF/SI/LB195.pdf |
BillText | https://nebraskalegislature.gov/FloorDocs/109/PDF/Intro/LB195.pdf |
Loading...